Company Overview
American HealthCare Capital is pleased to exclusively present an emerging Advanced Health Monitoring Company for sale in the Northeast. The Company has a special arrangement with a multi-billion smartwatch manufacturer, enabling the company to transform a smartwatch into a standalone device with FDA approved features, designed to replace many individual devices, while maintaining the capability to make and receive phone calls.
The company is positioned with the most comprehensive health management and emergency help features in the wearable industry. Features include monitoring of temperature, heart rate, ECG/Atrial fibrillation, blood oxygen, sleep, and steps. Our HealthAlert™ feature automatically alerts caregivers or providers if vital measurements are not within safe ranges.
To ensure better health outcomes, medication reminders help improve medication adherence rates, a problem correlated to 125,000 deaths per year and 10% of all hospital admissions, while custom reminders improve compliance with medical condition management requirements.
Financial Overview
For health emergencies, the watch provides one-press emergency calls, fall detection, and GPS updated every 30 minutes, enabling the device to replace medical alert pendants (PERS), a $2.3 billion industry in the U.S. that uses outdated technology, and eliminates the stigma associated with those devices.
The global Personal Emergency Response Systems (PERS) market is projected to grow significantly over the next decade. It was valued at $8.2 billion in 2022 and is expected to reach $10.7 billion by 2026, with a compound annual growth rate (CAGR) of 6.6%. By 2027, the market is anticipated to reach $11.4 billion.
Perhaps most importantly, the wearable is integrated with Clinical Remote Patient Monitoring where Medicare CPT reimbursements make the program practically free for patients while generating profits and improved patient outcomes for physician groups.
The Company offers a “private pay” program for a 12-Month and 24-month “Gold” Subscription, and a “Platinum” Subscription which includes an interface with the patient’s Primary Care Physician for Remote Patient Monitoring and is paid for by Medicare.
The company has a monthly recurring revenue (MRR) model. The payor mix will be a combination of self-pay subscriptions and Medicare reimbursements for Remote Patient Monitoring sold through Channel Partner Networks recently established. After significant research and development time and financial contributions by the owners of approximately $1.7 million, the Company is ready to launch its advanced health monitoring solutions to the general public and healthcare community.
In 2023 and 2024, the company tested the market, generating sales of $8,724 and $11,840 respectively, while reducing losses from $233,800 in 2023 to $53,593 through 9-30-2024.
At the present time, the Company is positioned for significant additional growth with the high and growing demand for patient health monitoring solutions, remote patient monitoring applications, the continuously aging population, never-ending efforts to reduce overall healthcare costs, and growing recognition within the healthcare provider community, all of which a new owner could build upon.
The majority owner (CEO) is interested in remaining with the Company in a similar capacity for several more years to provide assistance for the new owner. The remaining minority owners would not remain with the Company. The administrative staff are all expected to remain with the Company following the transition to a new owner.
Staff Overview
The majority owner (CEO) is interested in remaining with the Company in a similar capacity for several more years to provide assistance for the new owner. The remaining minority owners would not remain with the Company. The administrative staff are all expected to remain with the Company following the transition to a new owner.
Asking Price
The asking price for this opportunity is to be determined and to reflect the valuation range determined by an independent business valuation expert.
